BioFront
Tallahassee
About BioFront
BioFront Technologies is a Florida corporation focused on manufacturing enzyme-linked immuno-sorbent assay (ELISA) kits, lateral flow devices (LFDs) and related products. It is their mission to serve food manufacturers and others within the food safety industry by offering innovative and reliable products for food allergen detection and analysis. Their MonoTraceTM ELISA kits represent the first comprehensive line of monoclonal antibody-based assays aimed at helping industry professionals accurately detect and quantify trace amounts of food allergens in complex matrices. MonoTrace ELISAs incorporate precisely defined sets of monoclonal antibodies targeting major allergenic proteins that may be present in foods or on food contact surfaces. MonoTrace ELISAs provide an unmatched union of specificity and sensitivity in food safety testing by incorporating precisely defined sets of monoclonal antibodies optimized to detect major food processing-resistant allergens while minimizing cross-reactivity and food matrix interference.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Last round: Series Unknown (May 2013)
- Website: biofronttech.com
- Phone: (850)727-8107
Industries & Categories
Agriculture, Biotechnology, Food and Beverage, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/biofront-2728414 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.